A Phase IIIb, Multi-national, Multi-center, Subject- and Investigator-Masked Extension Study Assessing the Long Term Safety of PRN Intravitreal Injections of DE-109 in Subjects Achieving Clinical Benefit During the SAKURA Study (SPRING Study)